Investing in and building breakthrough biotech companies

Our Portfolio

Unconstrained by institution, geography or stage of company development; we have the ability to source the best life science innovation without restriction. We partner with the most ambitious entrepreneurs to build companies around game changing life science innovation.

View full portfolio

Video

Takeda

Takeda is a global, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing better health and a brighter future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology, Neuroscience and Rare Diseases.

UCB

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases in immunology or neurology. UCB is listed on Euronext Brussels (symbol: UCB).

Fosun

Fosun is a multinational company that has been listed on the main board of the Hong Kong Stock Exchange (00656.HK) since 2007. Fosun's mission is to create Customer-to-Maker ecosystems in health, happiness and wealth, providing high-quality products and services for families around the world.

Ipsen

Ipsen is a global biopharmaceutical group focused on innovation and specialty care. The group develops and commercialises innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Diseases.

Takeda

UCB

Fosun

Ipsen

Partners

Arix has developed a wide network that includes pharma companies, research accelerators and universities. Through this network, Arix is able to identify new technologies and discoveries that provide a rich pipeline of potential investments.